ALKS:Ord/Alkermes plc - Stock Price Quote and Dividend Data

ALKS STOCK PRICE LATEST CLOSE

$28.19

EXCHANGE

NASDAQ

ALKS

Ord/Alkermes plc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Stock Split Date & FactorNov. 16, 2023 & 0.9296
Split Payment TypeSpin-off
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ALKS

Ord/Alkermes plc Stock Price Information

ALKS Stock Price Latest Close$28.19
52-Week Low/High Stock Price$22.90 - $36.45
Percent Held by Institutions94.02%
Revenue$1,987,618,000
Net Income$513,573,000
Cash Flow$629,521,000
EPS0.90%
Market Cap$4,584,088,660
Issue TypeCommon, ordinary, ADR, etc.
PE Ratio13
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months8.72%
Total Return Last 3 Years2.34%
Total Return Last 5 Years91.56%
Latest Trade DateApr. 08, 2025
ALKS

Ord/Alkermes plc Annual Stock Dividends

No Data available for Payment History.

ALKS

Ord/Alkermes plc Dividend Payment History

No dividends retrieved for ALKS
ALKS

Ord/Alkermes plc Other Dividend Details

Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. Co. has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders.

Web Sitewww.alkermes.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Ord/Alkermes plc Dividend Stock News and Updates

Feb. 16, 2024ALKS STOCK PRICE INCREASE: Ord/Alkermes plc on 02-16-2024 increased stock price > 10% from $27.99 to $32.56

Apr. 28, 2022ALKS STOCK PRICE INCREASE: Alkermes plc on 04-28-2022 increased stock price > 10% from $27.14 to $30.38

Feb. 17, 2022ALKS STOCK PRICE INCREASE: Alkermes plc on 02-17-2022 increased stock price > 10% from $23.31 to $26.79

Nov. 10, 2021ALKS STOCK PRICE DECREASE: Alkermes plc on 11-10-2021 decreased stock price > 10% from $29.33 to $24.83

Aug. 13, 2021ALKS STOCK PRICE 52 WEEK HIGH: Alkermes plc on 08-13-2021 hit a 52 week high of $28.96

Feb. 12, 2021STOCK PRICE DECREASE: Alkermes plc (NASDAQ: ALKS) on 02-12-2021 decreased stock price > 10% from $22.93 to $20.02

Dec. 11, 2020STOCK PRICE INCREASE: Alkermes plc (NASDAQ: ALKS) on 12-11-2020 increased stock price > 10% from $18.35 to $20.68

Apr. 30, 2020CLOSE PRICE DECREASE: Alkermes plc (NASDAQ: ALKS) on 04-30-2020 decreased close price > 10% from $16.10 to $14.40

Mar. 17, 2020CLOSE PRICE DECREASE: Alkermes plc (NASDAQ: ALKS) on 03-17-2020 decreased close price > 10% from $16.14 to $13.99

Feb. 06, 2020CLOSE PRICE INCREASE: Alkermes plc (NASDAQ: ALKS) on 02-06-2020 increased close price > 10% from $17.52 to $19.40

More Ord/Alkermes plc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 09, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-09-2025 decreased stock price > 10% from $16.45 to $14.21

Apr. 09, 2025RNTX STOCK PRICE DECREASE: Rein Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $1.64 to $1.39

Apr. 09, 2025IRD STOCK PRICE DECREASE: Opus Genetics Inc on 04-09-2025 decreased stock price > 10% from $0.85 to $0.75

Apr. 09, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $4.05 to $3.61

Apr. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 04-09-2025 decreased stock price > 10% from $1.26 to $1.13

Apr. 09, 2025KAPA STOCK PRICE DECREASE: Kairos Pharma Ltd on 04-09-2025 decreased stock price > 10% from $1.14 to $0.97

Apr. 09, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-09-2025 decreased stock price > 10% from $0.87 to $0.65

Apr. 09, 2025ZBIO STOCK PRICE DECREASE: Zenas BioPharma Inc on 04-09-2025 decreased stock price > 10% from $7.75 to $6.77

Apr. 09, 2025EVOK STOCK PRICE DECREASE: Com Par $0.0001/Evoke Pharma Inc on 04-09-2025 decreased stock price > 10% from $2.35 to $2.07

Apr. 09, 2025TNFA STOCK PRICE DECREASE: TNF Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $0.37 to $0.26

More Pharmaceuticals Dividend News
X
Search Dividend Investor